Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ablation, absolute, arrhythmia, arrythmia, Bazett, cardiac, clarify, cognitive, collapse, confidence, database, de, depth, dismissed, doubtful, education, EMEA, escalating, estate, FARESTON®for, fatal, feedback, finasteride, formula, fundamental, Gleason, hoc, imperfect, indirectly, interval, intervention, marker, moxifloxacin, musculoskeletal, ophthalmic, oxidative, parallel, Pharmacopeia, pharmacovigilance, Plaza, precachexia, preclinicalin, prolong, prolongation, prolonged, prompt, proportionate, QT, QTcB, quoted, ready, real, rental, retrospective, Rev, Robinson, semen, slightly, sought, statute, stopping, suggested, surrogate, symptomatic, TN, topline, toremifenein, toremifeneor, toremifenewithin, Toyota, turmoil, turnover, underlying, unprecedented, unrecognized, urethral, violate, vitroandin, withstanding
Removed:
ACAPODENE, accessible, Andrew, anticipation, APB, approvable, audience, Australia, Barnette, Clarkson, Coagulation, direct, distinct, dutasteride, Endocrine, executed, flash, frequency, Gary, Gastrointestinal, graduate, inaccurate, indirect, initiating, Italy, Japan, magnitude, meaningfully, noninfringing, obstructive, Organization, perspective, pharmacology, presence, proven, redacted, Regional, resale, restricted, reviewed, Reviewer, Salem, satisfaction, shortly, Solvay, subjective, submitting, Sweden, TAP, taxable, Tessera, transition, unanticipated, underwriting, underwritten, unusable, West
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 EX-10.1
- 10.2 EX-10.2
- 10.3 EX-10.3
- 10.4 EX-10.4
- 10.8 EX-10.8
- 10.9 EX-10.9
- 10.10 EX-10.10
- 10.11 EX-10.11
- 10.27 EX-10.27
- 10.29 EX-10.29
- 10.38 EX-10.38
- 10.44 EX-10.44
- 10.47 EX-10.47
- 10.48 EX-10.48
- 10.49 EX-10.49
- 10.50 EX-10.50
- 10.51 EX-10.51
- 10.52 EX-10.52
- 10.53 EX-10.53
- 10.54 EX-10.54
- 12.1 EX-12.1
- 23.1 EX-23.1
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- 32.2 EX-32.2
Related press release
ONCT similar filings
Filing view
External links
Exhibit 12.1
GTx, Inc.
Computation of Deficiency of Earnings Available to Cover Fixed Charges
Computation of Deficiency of Earnings Available to Cover Fixed Charges
Year Ended December 31, | ||||||||||||||||||||
2008 | 2007 | 2006 | 2005 | 2004 | ||||||||||||||||
Loss: | ||||||||||||||||||||
Pretax loss from continuing operations | $ | (51,780 | ) | $ | (40,359 | ) | $ | (35,510 | ) | $ | (36,839 | ) | $ | (22,348 | ) | |||||
Fixed charges (from below) | 89 | 35 | 32 | 32 | 21 | |||||||||||||||
Total loss | $ | (51,691 | ) | $ | (40,324 | ) | $ | (35,478 | ) | $ | (36,807 | ) | $ | (22,327 | ) | |||||
Fixed charges: | ||||||||||||||||||||
Estimated interest portion of rent expenses | $ | 89 | $ | 35 | $ | 32 | $ | 32 | $ | 21 | ||||||||||
Total fixed charges | $ | 89 | $ | 35 | $ | 32 | $ | 32 | $ | 21 | ||||||||||
Coverage deficiency | $ | (51,780 | ) | $ | (40,359 | ) | $ | (35,510 | ) | $ | (36,839 | ) | $ | (22,348 | ) | |||||